Medical Malpractice – Failure to diagnose Breast Cancer: Update on the Dense Breast Legislation
Doctors often fail to diagnose cancer in women with dense breast tissue because mammograms screenings are not reliable for women with this condition. Recent statistics and studies also show that women with dense breast tissue have a higher risk of developing breast cancer. Therefore advocacy groups have been pushing for legislation that requires doctors to report breast density to their patient. In New York, failure to inform a patient about dense breast tissue is now against the law and may support a claim of medical malpractice. The legislation was signed by Governor Cuomo on July 23 2012 and took effect last January. A total of 18 states have enacted dense breast notification laws, and 10 more have laws pending. Who is supposed to do the reporting and what they are supposed to tell patients varies from state to state.
In “Dense Breast Legislation in the United States: State of the States” published in the December issue of the Journal of the American College of Radiology, Soudabeh Fazeli Dehkordy, MD, MPH, and Ruth C. Carlos, MD, MS, from the Department of Radiology at the University of Michigan School of Medicine in Ann Arbor provide a detailed review of the state of this law at states and federal level.

New York Personal Injury Attorneys Blog


Every drug with two names, brand name and generic name, is a medication error waiting to happen, writes Theresa Brown in her latest Opinion in The New York Times blog.
The risk of
A doctor can commit medical malpractice if he is not properly trained to use the Electronic Medical Record (EMR) system. In a recent case study Web Morbidity and Mortality looks at the case of an epileptic patient who experienced temporary toxicity because of a medication error linked to improper use of EMR.
Central Line-Associated Bloodstream Infections (CLABSI) are often the result of medical malpractice. An estimated 250,000 CLABSIs occur every year in the US with 800,000 of them happening in the emergency room. More than 30,000 people die from CLABSI in the US every year. The CDC estimates that the yearly cost related to CLABSI is $1 billion.